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Ethnic differences in adipose tissue distribution may contribute to different chronic disease risks across ethnic groups, and
adipokines may mediate the risk. In a cross-sectional study, we examined ethnic differences in adipokines and inflammatory
markers as related to body mass index (BMI) among 183 premenopausal women with Caucasian and Asian ancestry. General
linear models were used to estimate adjusted mean levels of leptin, adiponectin, interleukin-6, and C-reactive protein (CRP).
Asian women had significantly lower serum levels of leptin, adiponectin, and CRP than Caucasian participants (P ≤ .01) across
all levels of BMI. Among overweight and obese women, Asians showed a stronger association of CRP with leptin (β = 1.34 versus
β = 0.64) and with adiponectin (β = −0.95 versus β = −0.75) than Caucasians. Compared to Caucasians of similar BMI, Asians
may experience a higher chronic disease risk due to lower levels of adiponectin despite their lower levels of leptin.
1. Introduction
Accumulating epidemiologic evidence suggests that the effect
of obesity on chronic disease risk differs by ethnicity [1].
Asians experience a higher risk for hypertension, diabetes,
and cardiovascular disease at lower levels of body mass index
(BMI) compared to Caucasians [1–3]. For example, Japanese
Americans experience a 2-fold higher diabetes risk than
Caucasians, with higher risk at all BMI levels [3]. Ethnic dif-
ferences in body composition and adipose tissue distribution
may explain the significant interaction of ethnicity and BMI
on chronic disease risk. Particularly, a higher proportion of
abdominal visceral relative to subcutaneous adiposity among
Asians than Caucasians [4, 5] may be responsible for insulin
resistance and other adverse metabolic health effects [6, 7].
Biomarkers linking adiposity, inflammation, and disease,
such as C-reactive protein (CRP) and interleukin-6 (IL-6),
have been investigated [8]; however, no biomarker has been
identified that is associated with the ethnic heterogeneity in
chronic disease risk.
Adipocyte-derived hormones, leptin and adiponectin,
are likely candidates for elucidating the biological mech-
anisms underlying ethnic differences in disease risk. Lep-
tin and adiponectin respond to increasing adiposity in a
reciprocal manner [9], and the plasma leptin to adiponectin
ratio may be a potential measure of insulin resistance
[10]. It is unclear whether leptin and adiponectin are
specific biomarkers for adipose tissue distribution; however,
it appears that adiponectin concentrations are predomi-
nantly determined by visceral and leptin by subcutaneous
adipose tissue [11]. Released by adipose tissue after insulin
stimulation [12], leptin may serve as a possible link between
nutritional status and immune function [13]. Adiponectin
possesses strong anti-inflammatory, antiatherogenic, and
insulin-sensitizing properties [14, 15]. Low adiponectin
is an independent predictor of incident type 2 diabetes
[16] and cardiovascular disease [17]. Furthermore, lower
adiponectin levels have been observed in Chinese, Japanese,
Korean, and South Asians compared to Caucasians [18–
21].
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The objective of this study was to determine whether
there are ethnic differences in serum leptin and adiponectin
levels relative to BMI and their impact on inflammatory
markers as predictive factors for future chronic disease
[22] among premenopausal women of Asian American,
Caucasian, and Native Hawaiian background. Specifically,
we hypothesized that adipokine levels may link obesity with
inflammatory markers.
2. Materials and Methods
2.1. Study Design. This analysis used data from a nutri-
tional intervention study [23]. The University of Hawaii
Committee on Human Studies and the Kaiser Permanente
Institutional Review Board approved the study protocol. All
participants were recruited through mailed invitations from
mammographic screening clinics on the island of Oahu,
Hawaii. Eligible women had a normal screening mammo-
gram and regular menstrual cycles. All subjects signed an
informed consent form and gave written permission to
use frozen samples for future analyses. In the nutritional
intervention trial, 220 premenopausal women aged 35–47
years were randomized to a soy diet or to the control group
as described previously. Women were excluded for use of
oral contraceptives or other sex hormones, diagnosis of
cancer, hysterectomy, no intact ovary or no regularmenstrual
periods, or high soy intake. Data obtained from baseline
serum samples were used in the current investigation; BMI
and biomarkers were available for 183 women. Ethnic
background was self-reported and when possible women of
mixed ancestry were assigned to one ethnic category with
Native Hawaiian having the highest priority.
2.2. Analytical Methods. Serum levels of leptin, adiponectin,
and IL-6 were assessed by double-antibody enzyme-linked-
immunosorbent-assay (ELISA) (R&D Systems, Minneapolis,
MN, USA) according to the manufacturer’s specifications.
The CRP assay was based on a latex particle-enhanced
immunoturbidimetric method using a kit (Pointe Scientific,
Inc, Lincoln Park, MI, USA) and a Cobas Mira Plus clinical
autoanalyzer. The assay quality was assessed by 49 blinded
controls from a pooled sample donated by 10 premenopausal
volunteers. The mean intrabatch coefficient of variation
(CV) for leptin, adiponectin, IL-6, and CRP were 4.6%,
14.0%, 6.8%, and 6.1%, whereas interbatch CVs were 9.5%,
24.9%, 17.8%, and 18.2%, respectively. The higher intra- and
interbatch CVs with adiponectin were attributable to less
precise measures because the studies samples contained a
lower range of the standard curve for the assay.
2.3. Statistical Analysis. The primary goal of these analy-
ses was to determine any ethnic differences in measured
biomarkers (leptin, adiponectin, IL-6, and CRP) for women
with similar BMI. Secondary analyses included evaluating
ethnic-specific models to examine the relation of leptin and
adiponectin with CRP. Leptin, adiponectin, CRP, and IL-
6 were log transformed to normalize their distributions.
General linear models were applied to estimate mean levels
for biomarkers by ethnicity or BMI category and differences
in mean values were made using Tukey’s Test for multiple
comparisons. Our ethnic-specific analyses focused on dif-
ferences between Asians and Caucasian women due to the
small sample size for Native Hawaiian/Other women.Models
were adjusted for BMI (continuous) and/or ethnicity (Asian,
Caucasian, Native Hawaiian/Other) as appropriate. The fit of
the models was assessed using R2 and residual diagnostics.
Statistical computing was conducted using SAS version 9.2
(SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Ethnic Differences in Biomarkers. The participants were
of diverse ethnicity: 67 Caucasian, 23 Native Hawaiian,
49 Japanese, 14 Chinese, 11 Filipino, and 19 mixed/other
ethnicities. Japanese, Chinese, and Filipino women were
combined into one group (Asians) due to small sample
sizes. The mean age of the study population was 43.0 ±
2.9 years and did not differ across ethnic groups (P =
.26). Close to half of the women (49%) were overweight
or obese, with substantial ethnic differences in BMI and
measures of adiponectin, leptin, IL-6, and CRP (Table 1).
BMI was lower among Asians than in the two other ethnic
groups (P < .05). Mean levels of leptin, IL-6, and CRP
were significantly lower in Asian than in Caucasian women,
but the Native Hawaiian/Other group did not differ from
Caucasians. Adiponectin was also lower in Asian (P < .01)
and in Native Hawaiian/Other women (P < .02) than in
Caucasians. The leptin to adiponectin ratio did not differ
across ethnic groups (P = .10).
3.2. Differences in Biomarkers by BMI. Mean leptin levels
were significantly higher in overweight and obese relative
to normal weight women (geometric means: 18.0 and 34.8
versus 8.8 ng/mL, respectively; Ptrend < .0001). The relation
was reversed for adiponectin with significantly lower levels in
overweight and obese women; geometric means for normal
weight, overweight, and obese women were 8.3, 6.3, and
5.6 μg/mL, respectively (Ptrend < .0001). Among overweight
and obese women, Asian women had lower serum levels
of both leptin (Figure 1(a)) and adiponectin (Figure 1(b)),
while in women with normal BMI, Asians had lower levels
of adiponectin but similar levels of leptin, as compared with
Caucasians. No ethnic differences were observed for the
leptin to adiponectin ratio irrespective of BMI (Figure 1(c)).
Greater ethnic differences were observed in overweight and
obese women for IL-6 (Figure 1(d)) and CRP (Figure 1(e))
than normal weight women.
3.3. Associations with CRP. A stronger correlation with CRP
was observed for leptin than for adiponectin (r = 0.50,
P < .0001 versus r = −0.20, P = .01). CRP remained
positively associated with leptin and inversely associated
with adiponectin after adjustment for BMI and ethnicity
(Table 2); only the association with leptin reached statistical
significance. In stratified models by BMI group, leptin
remained statistically significant with similar magnitude of
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Table 1: Study participant characteristics by ethnicity.
Asian Caucasian Native Hawaiian/other ethnic groups
N 74 67 42
Percent overweight (25.0–29.9 kg/m2) 26 22 33
Percent obese (>30.0 kg/m2) 15 25 31
BMI, kg/m2 24.6 (4.4)a 27.0 (6.8) 27.4 (5.4)
Age, y 43.4 (2.7) 42.9 (3.0) 42.6 (3.2)
Leptin (ng/mL)b 11.7 (13.5)a 19.5 (20.2) 20.0 (16.4)
Adiponectin (μg/mL)b 7.3 (4.6)a 9.1 (6.0) 6.6 (5.5)a
Leptin : adiponectin ratio (ng/μg)b 1.7 (3.0) 1.9 (3.6) 3.0 (4.3)
IL-6 (pg/ml)b 0.9 (0.7)a 1.1 (1.0) 0.9 (0.6)
CRP (mg/L)b,c 0.6 (1.5)a 1.7 (3.3) 1.1 (1.5)
Abbreviations: BMI: body mass index, IL-6: interleukin-6, CRP: C-reactive protein.Unless otherwise noted, mean and standard deviation provided for each
variable.
aP value < .05 from one-way analysis of variance (Tukey’s Test) for difference in mean values from Caucasian.
bMedian and interquartile range provided for skewed variables. Log transformed value used for P value.
cMissing value for CRP (n = 1).
association with CRP, however, a statistically significant
inverse association with adiponectin was only observed in
overweight and obese women. In ethnic-specific models,
among overweight and obese women we observed a stronger
association with CRP for leptin (β = 1.34 versus β = 0.64) and
for adiponectin (β = −0.95 versus β = −0.75) in Asian than
Caucasian women; however, the modification by ethnicity
was not statistically significant (P for interaction of leptin or
adiponectin with ethnicity on CRP: 0.21 for leptin and 0.74
for adiponectin).
4. Discussion
Using baseline data from a nutritional intervention study in
premenopausal women, the authors found ethnic differences
in levels of adipokines and inflammatory markers with varia-
tion by BMI. Significantly lower leptin levels and consistently
lower levels of the inflammatory markers CRP and IL-6 were
observed in Asians than in Caucasians among overweight
and obese, but not normal weight women. In contrast,
adiponectin levels were lower for Asian than Caucasian
women across the range of BMIs. Because lower plasma
adiponectin levels and higher leptin, CRP, and IL-6 levels are
associated with metabolic disorders [16, 24, 25], our findings
suggest that the higher risk of chronic disease among Asians
compared to Caucasians, particularly within the normal-
weight range, may be in part due to lower adiponectin
rather than leptin levels or proinflammatory marker levels.
Overall, leptin was a strong predictor of CRP independent
of BMI, whereas adiponectin was inversely associated with
CRP in overweight and obese women only. Of interest,
in overweight and obese women, Asians showed stronger
associations for CRP with leptin and adiponectin compared
to Caucasians. The findings support the hypothesis that
leptin and adiponectin link adipose tissue with inflammation
and suggest that adiponectin may play a role in the elevated
risk for chronic disease despite lower BMI and leptin levels in
Asian women.
Consistent with findings from the present study, lower
serum adiponectin levels independent of BMI have been
observed in women of Chinese [18], Korean [19], and
South Asian [18, 21] ancestry than in Caucasian women.
Low adiponectin levels are associated with abnormal glu-
cose homeostasis, abnormal lipid metabolism, and insulin
resistance in normal and in overweight or obese women
[26, 27]; however, it is unclear whether low adiponectin
levels mediate higher disease risk in Asians compared
to Caucasians with comparable BMI [18, 21]. Because a
clustering of increased metabolic, adipogenic, and proin-
flammatory factors are associated with lower adiponectin
levels [28], complex multifactorial mechanisms of many
contributing mediators may be involved rather than any
single mechanism. One hypothesis is that higher proportions
of abdominal visceral relative to subcutaneous adiposity
among Asians than Caucasians [4, 5] may account for the
observed lower levels of adiponectin in Asian women as
serum adiponectin levels are determined predominantly by
visceral rather than subcutaneous adipose tissue [11, 29].
The accumulation of visceral adiposity is associated with
metabolic risk factors for diabetes and cardiovascular disease
[30] and adiponectinmay be an importantmediator [31, 32].
The finding that leptin is a stronger predictor of CRP
than adiponectin is consistent with other studies [33,
34]. Proinflammatory cytokines, primarily IL-6 but also
other cytokines including tumor necrosis factor-α (TNF-
α), regulate the hepatic synthesis of CRP [35]. Adipose
tissue represents a common source for both leptin and these
inflammatory cytokines, which are secreted by adipocytes
[36, 37] and macrophages residing in adipose tissue [38].
In this and other studies in apparently healthy women
[39, 40], leptin predicted CRP levels independent of BMI,
suggesting that adipose tissue only partially mediates the
leptin-CRP association, and alternative pathways unrelated
to general adiposity may be involved. For example, leptin
may upregulate CRP levels by directly inducing IL-6 pro-
duction [41] and by the leptin receptor, which has been
4 Mediators of Inflammation
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Figure 1: Ethnic difference in the biomarkers by BMI level. Abbreviations: BMI: body mass index; IL-6: Interleukin-6; CRP: C-reactive
protein. aP values for ethnic heterogeneity from analysis of variance with log transformed values and adjusted for BMI categories.
shown to have intracellular signaling capabilities of IL-6-
type cytokine receptors [42]. On the other hand, adiponectin
may indirectly reduce CRP levels by inhibiting TNF-α
production and, therefore, modulating the proinflamma-
tory cascade that mediates CRP production [43]. In this
study, adiponectin was inversely associated with CRP in
overweight and obese women only, whereas the adiponectin-
CRP association was independent of BMI in previous studies
among apparently healthy postmenopausal women [28] and
women with type-2 diabetes [44]. However, adiponectin
may have divergent prognostic implications depending on
the population characteristics. Leptin and adiponectin were
stronger predictors of CRP among Asian than Caucasian
overweight and obese women, but not in overall BMI-
adjusted models indicating that leptin and adiponectin
link adipose tissue with inflammation and the underlying
mechanisms may be heterogeneous across ethnic groups.
A limitation of the study is the possibility of a Type I error
due to assessing multiple correlations with small numbers
of measured serum variables; therefore, our results are
explorative and hypothesis-generating only. Furthermore,
the study included only a few women at the low and
high extremes for BMI (i.e., <20 kg/m2 or >35 kg/m2). For
example, the few Caucasians in the lower-normal range
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Table 2: Association of leptin and adiponectin with CRP by ethnicitya.
All womenb (n = 182) Asian (n = 74) Caucasian (n = 67)
β (95% CI) Pc β (95% CI) Pc β (95% CI) Pc Pd
Overall
Leptin 0.40 (0.05, 0.76) 0.03 0.36 (−0.32, 1.04) 0.30 0.32 (−0.27, 0.91) 0.29 0.52
Adiponectin −0.25 (−0.63, 0.12) 0.18 −0.18 (−0.83, 0.48) 0.59 −0.27 (−0.93, 0.39) 0.43 0.68
Normal weight (BMI < 25 kg/m2)
Leptin 0.49 (0.09, 0.90) 0.02 0.31 (−0.44, 1.06) 0.41 0.53 (−0.13, 1.19) 0.12 0.67
Adiponectin 0.08 (−0.49, 0.65) 0.78 0.39 (−0.54, 1.32) 0.41 −0.06 (−1.09, 0.96) 0.91 0.52
Overweight/obese (BMI ≥ 25 kg/m2)
Leptin 0.66 (0.19, 1.13) 0.01 1.34 (0.56, 2.12) <0.01 0.64 (−0.12, 1.39) 0.10 0.21
Adiponectin −0.58 (−1.07, −0.09) 0.02 −0.95 (−1.74, −0.16) 0.02 −0.75 (−1.60, 0.09) 0.08 0.74
Abbreviations: BMI: body mass index, CRP: C-reactive protein.
aValues are estimates from analysis of covariance of CRP, 95% confidence intervals (CI), and P values. CRP, leptin, and adiponectin were log-transformed for
all models. Model adjusted for BMI (continuous) and ethnicity (Asian, Caucasian, Native Hawaiian/other ethnic groups) as appropriate.
bOne woman with missing CRP measurement was excluded from analyses.
cP- value for the association between leptin or adiponectin and CRP.
dP- value for interaction by ethnicity.
of BMI and the few Asians in the high BMI categories
may explain the similar adiponectin levels in these extreme
BMI categories. As with any cross-sectional design, the
directionality of associations remains unclear. Also, we did
not have measures of abdominal fat distribution (visceral
versus subcutaneous) or total body fat and were unable to
assess whether the addition of measures for visceral adiposity
attenuated ethnic-specific associations. It is possible that
leptin, CRP, or IL-6 levels may be confounded by ethnic
differences in inflammatory or autoimmune conditions [45];
however, this is unlikely given that the women in this study
were apparently healthy and relatively young. Additional out-
come measures of interest that may have further elucidated
the significance of lower adiponectin in Asian women with
respect to metabolic markers include plasma glucose, insulin
and lipid profiles, and visfatin, an adipocyte-derived protein
predominantly found in visceral adipose tissue. Our findings
contribute to the limited data available on apparently healthy
premenopausal women of normal BMI. Additional strengths
of our study include an ethnically diverse study population,
well-controlled blood collection, and reliable assays.
In conclusion, we propose that lower adiponectin levels
in Asian compared to Caucasian women may be attributed
to higher amounts of visceral adipose tissue at any given
level of total adiposity. Leptin is a stronger predictor of
CRP; however, in overweight and obese women, Asian
women showed a stronger link between circulating CRP
with both leptin and adiponectin. As CRP is a predic-
tive factor for future chronic disease, adipokines may be
important mediators of risk for Asian women. Nevertheless,
studies are needed that measure visceral, subcutaneous, and
total adipose tissue (e.g., magnetic resonance imaging or
computed tomography dual energy X-ray absorptiometry
study of adiposity distribution) among a weight-diverse
population to clarify the association between adipokines and
distribution of adiposity tissue. Additionally, future studies
that include outcome measures such as insulin resistance,
diabetes, andmetabolic syndrome as well as heart disease and
rheumatological conditions are needed to further elucidate
whether adiponectin is a key link to explain the ethnic
differences in disease risk in Asians and Caucasians.
Abbreviations
BMI: Body mass index
CRP: C-reactive protein
CV: Coefficient of variation
IL-6: Interleukin-6
TNF-α: Tumor necrosis factor-α.
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